Large granular lymphocytic leukemia associated with Lambert-Eaton Myasthenic Syndrome: A case report

Leukemia Research Reports

Volumn 2, Issue 1, 2013, Pages 32-33

  Lemal, Richard ^a   Chaleteix, Carine ^a   Minard, Patrice ^b   Roche, Corinne ^c   Bay, Jacques Olivier ^a   Tournilhac, Olivier ^a   Lamy, Thierry ^d  

^a UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^b CH Vichy   (France)

^c Services de Neurologie   (France)

^d UNIVERSITÉ DE RENNES 1   (France)

Author keywords

Lambert Eaton Myasthenic Syndrome; Large granular lymphocytic leukemia; LGL leukemia

Indexed keywords

METHOTREXATE; STEROID;

AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC TEST; DISEASE ASSOCIATION; EATON LAMBERT SYNDROME; HUMAN; LARGE GRANULAR LYMPHOCYTE LEUKEMIA; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

EID: 84878346129     PISSN: 22130489     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lrr.2013.02.004     Document Type: Article

References (12)

1. Zhang R., Shah M.V., Loughran T.P. The root of many evils: indolent large granular lymphocyte leukaemia and associated disorders. Hematological Oncology 2010, 28(3):105-117.
2. Titulaer M.J., Lang B., Verschuuren J.J. Lambert-Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies. Lancet Neurology 2011, 10(12):1098-1107.
3. Martin-Moutot N., De Haro L., Seagar M. Distinct evolution of calcium channel antibody types in Lambert-Eaton myasthenic syndrome. Journal of Neuroimmunology 2008, 197(1):47-53.
4. Tani T., Tanaka K., Idezuka J., Nishizawa M. Regulatory T cells in paraneoplastic neurological syndromes. Journal of Neuroimmunology 2008, 196(1-2):166-169.
5. Argov Z., Shapira Y., Averbuch-Heller L., Wirguin I. Lambert-Eaton myasthenic syndrome (LEMS) in association with lymphoproliferative disorders. Muscle and Nerve 1995, 18(7):715-719.
6. Portha C., Dupond J.L., Monnier G., Bosset J.F., Leconte des Floris R. Eaton-Lambert syndrome associated with multiple myeloma: resolution of the neuromuscular block after chemotherapy. La semaine des hÔpitaux: organe fondé par l'Association d'enseignement médical des hÔpitaux de Paris 1983, 59(17):1337-1339.
7. Homenda W., Hellmann A. Hodgkin's disease with systemic vasculitis and Lambert-Eaton myasthenic syndrome-case report. Wiadomości Lekarskie 2000, 53(9-10):574-578.
8. Wohl M.A., Wood J.K. Chronic myeloid leukaemia and a myasthenic syndrome. Acta Haematologica 1979, 62(4):214-218.
9. Titulaer M.J., Wirtz P.W., Willems L.N.A., van Kralingen K.W., P.A.E.S.Smitt, Verschuuren J.J.G.M. Screening for small-cell lung cancer: a follow-up study of patients with Lambert-Eaton myasthenic syndrome. Journal of Clinical Oncology 2008, 26(26):4276-4281.
10. Tĉtu B., Ro J.Y., Ayala A.G., Ordóñez N.G., Logothetis C.J., von Eschenbach A.C. Small cell carcinoma of prostate associated with myasthenic (Eaton-Lambert) syndrome. Urology 1989, 33(2):148-152.
11. Agarawal S.K., Birch B.R., Abercrombie G.F. Adenocarcinoma of the prostate and Eaton-Lambert syndrome. A previously unreported association. Scandinavian Journal of Urology and Nephrology 1995, 29(3):351-353.
12. Titulaer M.J., Verschuuren J.J.G.M. Lambert-Eaton myasthenic syndrome: tumor versus nontumor forms. Annals of New York Academy of Sciences 2008, 1132:129-134.